Cheryl A. Dean
Halifax, NS, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Targeted hyperthermia therapy (THT) using gold nanorods remodels the tumor microenvironment to sensitize murine microsatellite-stable colorectal cancer to immune checkpoint blockade.
Journal: Journal of nanobiotechnology
Published: January 05, 2026
Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods.
Journal: Journal of visualized experiments : JoVE
Published: October 27, 2025
Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI'S Nanotechnology Characterization Laboratory Service to the Research Community.
Journal: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
Published: April 08, 2025
LINC01929 mediates breast cancer immunosuppression and is an immunotherapy target.
Journal: iScience
Published: March 12, 2025
Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically 'cold' tumor models.
Journal: Frontiers in immunology
Published: October 16, 2024
ALDH1A3 is the switch that determines the balance of ALDH+ and CD24-CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer.
Journal: Oncogene
Published: May 02, 2024
Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis.
Journal: Metabolomics : Official journal of the Metabolomic Society
Published: August 31, 2021
LncRNA PART1 Promotes Proliferation and Migration, Is Associated with Cancer Stem Cells, and Alters the miRNA Landscape in Triple-Negative Breast Cancer.
Journal: Cancers
Published: May 17, 2021
Human-specific GAPDH qRT-PCR is an accurate and sensitive method of xenograft metastasis quantification.
Journal: Molecular therapy. Methods & clinical development
Published: October 17, 2020
Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug Resistance.
Journal: Molecular cancer therapeutics
Published: July 30, 2019
Last Updated: 09/26/2026